Local Infusion of Bupivacaine and Systemic Analgesics versus System Analgesics Alone in the Management of Postoperative Pain from Total Knee Replacement

2.50
Hdl Handle:
http://hdl.handle.net/10755/161233
Type:
Presentation
Title:
Local Infusion of Bupivacaine and Systemic Analgesics versus System Analgesics Alone in the Management of Postoperative Pain from Total Knee Replacement
Abstract:
Local Infusion of Bupivacaine and Systemic Analgesics versus System Analgesics Alone in the Management of Postoperative Pain from Total Knee Replacement
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2005
Author:Surace, Angela, MS, APRN, BC, CCRN
P.I. Institution Name:Riverside Methodist Hospital
Title:Project Coordinator
Contact Address:OUTCOMES MANAGEMENT, 3535 Olentangy River Road, Columbus, OH, 43214, USA
Contact Telephone:614-566-3729
The purpose of this clinical trial was to compare degree of
postoperative pain and medication utilization among knee arthroplasty
patients who did and did not receive an intraarticular infusion of
bupivacaine along with standard systemic analgesics. Patients 18 years and
older, who were scheduled for primary total knee arthroplasty (TKA)
consented to participate, were randomized into two groups. The
experimental group received a bolus of 30ml of 0.25% Bupivacaine via a
catheter which terminated in the capsule at the superior patella. This
bolus was followed by continuous infusion of Marcaine 0.5% at 2cc per hour
for the next 48 hours. The experimental and control groups were provided
with the usual postoperative pain management including intravenous (IVP)
Dilaudid for break through pain and scheduled doses of Oxycodone, Vioxx or
Celebrex for three days. Perception of pain, pain management and side
effects were collected from all subjects at days 1 and 3 postoperatively.
Total amounts of pain medications administered over the 3 days were also
collected. The findings indicate that randomization created similar groups
with regard to age, gender, length of stay and of operative analgesia. The
results indicated no differences between the groups in terms of
postoperative pain, doses of Oxycodone, Vioxx or Celebrex or the amount of
IVP Dilaudid administered for break through pain over the postoperative
period. Both groups did exhibit similar significant declines in measures
of pain over the postoperative period, while the experimental group
experienced greater pain than expected and reported less satisfaction with
pain management compared with the usual care condition. These findings
fail to support the efficacy of intraarticular infusions of narcotics as a
superior method of managing the postoperative pain among TKA patients.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleLocal Infusion of Bupivacaine and Systemic Analgesics versus System Analgesics Alone in the Management of Postoperative Pain from Total Knee Replacementen_GB
dc.identifier.urihttp://hdl.handle.net/10755/161233-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Local Infusion of Bupivacaine and Systemic Analgesics versus System Analgesics Alone in the Management of Postoperative Pain from Total Knee Replacement</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Surace, Angela, MS, APRN, BC, CCRN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Riverside Methodist Hospital</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Project Coordinator</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">OUTCOMES MANAGEMENT, 3535 Olentangy River Road, Columbus, OH, 43214, USA</td></tr><tr class="item-phone"><td class="label">Contact Telephone:</td><td class="value">614-566-3729</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">SuraceA@Ohiohealth.com</td></tr><tr><td colspan="2" class="item-abstract">The purpose of this clinical trial was to compare degree of <br/> postoperative pain and medication utilization among knee arthroplasty <br/> patients who did and did not receive an intraarticular infusion of <br/> bupivacaine along with standard systemic analgesics. Patients 18 years and <br/> older, who were scheduled for primary total knee arthroplasty (TKA) <br/> consented to participate, were randomized into two groups. The <br/> experimental group received a bolus of 30ml of 0.25% Bupivacaine via a <br/> catheter which terminated in the capsule at the superior patella. This <br/> bolus was followed by continuous infusion of Marcaine 0.5% at 2cc per hour <br/> for the next 48 hours. The experimental and control groups were provided <br/> with the usual postoperative pain management including intravenous (IVP) <br/> Dilaudid for break through pain and scheduled doses of Oxycodone, Vioxx or <br/> Celebrex for three days. Perception of pain, pain management and side <br/> effects were collected from all subjects at days 1 and 3 postoperatively. <br/> Total amounts of pain medications administered over the 3 days were also <br/> collected. The findings indicate that randomization created similar groups <br/> with regard to age, gender, length of stay and of operative analgesia. The <br/> results indicated no differences between the groups in terms of <br/> postoperative pain, doses of Oxycodone, Vioxx or Celebrex or the amount of <br/> IVP Dilaudid administered for break through pain over the postoperative <br/> period. Both groups did exhibit similar significant declines in measures <br/> of pain over the postoperative period, while the experimental group <br/> experienced greater pain than expected and reported less satisfaction with <br/> pain management compared with the usual care condition. These findings <br/> fail to support the efficacy of intraarticular infusions of narcotics as a <br/> superior method of managing the postoperative pain among TKA patients.</td></tr></table>en_GB
dc.date.available2011-10-26T23:18:03Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T23:18:03Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.